This is a temporary role (12 months contract) with the potential to transition into a permanent position.

Join an innovative and fast-growing biotech company making a real difference in the lives of patients with rare diseases. We are a dynamic, small biotech company that values agility, innovation, and the personal impact of every team member. As a member of our field force, you’ll play a pivotal role in supporting healthcare professionals (HCPs) in diagnosing a rare condition, contributing directly to improving patient outcomes in neurology and cardiology.

We are competing in a highly specialized market, and we need someone who can rise to the challenge and excel at building meaningful relationships with healthcare professionals across Switzerland with a strong focus on the Swiss Romandie region.

We are seeking an experienced and passionate Key Account Manager (KAM) with a primary focus on helping healthcare professionals (HCPs) diagnose patients with a rare disease. This role involves delivering key scientific data, education, and support to ensure that HCPs can identify and manage patients effectively. In addition to this core responsibility, you will help drive the adoption of our rare disease product and assist with the launch of our upcoming product focused on cardiology.

The KAM is a field-based expert, that strategically drives the commercial objectives of Alnylam’s (hereditary) transthyretin amyloidosis (h)ATTR program for Switzerland. You will work in close alignment and collaboration with functions of Medical Affairs, Clinical Research, Patient Advocacy, Market Access and Commercial, while ensuring full compliance with all relevant company, industry, legal, regulatory and ethical standards.

As the face of our brand in Switzerland with a strong focus on the Swiss Romandie region, you’ll have the autonomy to shape your territory, engage with decision-makers, develop & implement key-account plans and support the medical community in understanding and managing rare disease diagnoses.

Key Responsibilities

• HCP Support in Diagnosing Rare Diseases: Partner with cardiologists, neurologists, and other key HCPs to deliver scientific and clinical education that aids in the early and accurate diagnosis of a rare disease.
• Clinical Data Delivery: Present and explain complex scientific data in a clear, accessible manner to ensure HCPs fully understand the diagnostic tools and methodologies.
• Product Promotion: Once diagnosis is established, introduce and promote our rare disease product as a key solution for patient management. Ensure HCPs understand its clinical benefits.
• Support Product Launch: Assist in the launch of our next product, particularly with cardiologists, by building awareness, sharing data, and facilitating market adoption.
• Access and Relationship Building: Develop strong relationships with key HCPs across Switzerland, navigating access challenges and ensuring product adoption where necessary.
• Autonomy in Territory Management: Lead and manage your own territory and key account plans, developing strategies to educate HCPs while driving business objectives.

Qualifications

• Sales and Scientific Communication Experience: Proven success in pharmaceutical, biotech, or healthcare sales, especially in supporting HCPs with scientific and diagnostic knowledge. Experience with rare diseases, cardiology, or neurology is a plus.
• Diagnostic Focus: Ability to engage HCPs on the front lines of diagnosis, using clinical data and insights to support early disease identification.
• Access Knowledge: Experience navigating restricted markets, especially in Swiss Romandie, and building strong relationships with hard-to-reach HCPs.
• Entrepreneurial Spirit: A self-starter who thrives in a dynamic environment, eager to make a direct impact on patient outcomes and company success.
• Relationship-Driven: A natural networker with a talent for building and maintaining professional relationships with HCPs.
• Business Travel: Ability to travel within territory on a regular basis (around 80% of the time) including overnight and weekend travel if required and must hold a valid driver's license.
• Life Science Education: Strong preference for a Life Science degree
• Microsoft Office Skills: Proficient knowledge in Excel, PowerPoint, Word, etc. for project work and team collaboration are essential.
• Fluent French: Native or fluent proficiency in French (both written and oral), with professional proficiency in English. German is a plus.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.